Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BIAF Stock — bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. (BIAF)
Updated November 17, 2026.
BIAF is a stock. Total return is -99.9% over the past 4.2 years, 194.7 points behind SPY at 94.8%.
bioAffinity Technologies develops non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other lung diseases using flow cytometry technology, operating through diagnostic research and development and laboratory services segments. The company does not currently have an established distribution schedule. This security may appeal to investors seeking exposure to early-stage healthcare diagnostics companies, though it carries the risk profile typical of development-stage enterprises.
BIAF performance versus SPY
Total return is -99.9% over the past 4.2 years, 194.7 points behind SPY at 94.8%. Over the past year its total return — price change plus distributions reinvested — is -90.2%. Its deepest 1-year drawdown was 97.3%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -42.4% | — |
| 3M | -69.7% | — |
| 6M | -91.5% | — |
| YTD | -87.8% | — |
| 1Y | -90.2% | — |
| 2Y CAGR | — | -94.00% |
| 3Y CAGR | — | -84.90% |
| Since inception 2022-09-01 · 4.2 years | -99.9% | -83.00% |
BIAF key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 09/01/2022
- Distribution frequency
- None
- Last close
- $1.93 (as of 2026-11-17)
- Market cap
- $3,512,612
- Average volume
- 67,866
- Beta
- -1.047
- Payout ratio
- 0.0%
- EPS
- -$40.37
How Dividend Vision calculates returns
Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BIAF risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 97.3%.
Who may consider BIAF — and who may not
It is a weaker fit for investors who need monthly cash flow (BIAF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on BIAF
Frequently asked questions
Does BIAF pay monthly?
No. BIAF does not currently distribute.
When does BIAF pay a dividend?
BIAF does not currently distribute.
How has BIAF performed?
Total return is -99.9% over the past 4.2 years, 194.7 points behind SPY at 94.8%. Over the past year its total return — price change plus distributions reinvested — is -90.2%. Its deepest 1-year drawdown was 97.3%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.